首页|期刊导航|海南医科大学学报|基于网络药理学和实验验证探讨高尤-7味丸改善急性肾损伤的作用机制

基于网络药理学和实验验证探讨高尤-7味丸改善急性肾损伤的作用机制OA

Mechanism of Gaoyou-7 Pill in ameliorating acute kidney injury based on network pharmacology and experimental verification

中文摘要英文摘要

目的:探讨高尤-7味丸对急性肾损伤(acute kidney injury,AKI)的保护作用及机制.方法:通过网络药理学获取高尤-7味丸的活性成分和作用靶点,进行PPI网络分析.利用R语言对高尤-7味丸和AKI的共同靶点进行GO和KEGG富集分析,构建核心成分-潜在靶点-疾病-信号通路网络,对核心成分和核心靶点进行分子对接.建立脂多糖诱导的小鼠AKI模型,初步评价疾病模型和药效.H&E染色观察肾脏病理学变化,酶法试剂盒检测肾功能.qRT-PCR实验检测 TNF-α、IL-6、IL-1β的 mRNA表达水平,Western blot法检测PI3K、Akt、p-Akt的蛋白表达水平.结果:获得高尤-7味丸活性成分75种,筛选得到54个潜在靶点、7个核心成分(槲皮素、T-依兰油醇、棕榈酸、蛇麻烯、亚油酸、顺式肉桂醛、乙酸苯乙酯)、6个核心靶点(AKT1、TNF、IL6、TP53、IL1B、EGFR).GO和KEGG富集分析结果主要涉及转录因子、细胞分化、PI3K/Akt信号通路、IL-17信号通路、TNF信号通路、HIF-1信号通路.体内实验证明高尤-7味丸可以保护肾功能,降低TNF-α、IL-6、IL-1β水平,上调PI3K和p-Akt/Akt的表达.结论:高尤-7味丸通过多成分-多靶点-多途径治疗AKI,其可以调控PI3K/Akt通路,降低炎症因子水平,保护肾功能进而改善AKI,这为蒙药的临床合理应用和进一步开发研究提供理论依据.

Objective:To explore the renal protective effects and mechanisms of Gaoyou-7 Pill against acute kidney injury(AKI).Methods:Network pharmacology was employed to identify active ingredients and potential targets of Gaoyou-7 Pill,fol-lowed by PPI network analysis.Common targets of Gaoyou-7 Pill and AKI were subjected to GO and KEGG enrichment analyses using R software.A core component-potential target-disease-signaling pathway network was constructed,and molecular docking was performed between core components and key targets.A LPS-induced AKI mouse model was established to preliminarily eval-uate disease pathology and therapeutic efficacy.Renal histopathological changes were observed via H&E staining,and renal func-tion was assessed using enzymatic assay kits.qRT-PCR was utilized to measure mRNA levels of TNF-α,IL-6,and IL-1β,while Western blot was performed to detect protein expression of PI3K,Akt,and p-Akt.Results:A total of 75 active ingredients of Gaoyou-7 Pill were identified,with 54 potential targets and 7 core components(quercetin,T-muurolol,hexadecanoic acid,alpha caryophyllene,linoleic acid,cis cinnamaldehyde,phenethyl acetate)and 6 core targets(AKT1,TNF,IL6,TP53,IL1B,EG-FR)screened.GO and KEGG analysis revealed significant enrichment in transcription factor activity,cell differentiation,and sig-naling pathways including PI3K/Akt,IL-17,TNF,and HIF-1.In vivo experiments demonstrated that Gaoyou-7 Pill protected renal function,reduced the levels of TNF-α,IL-6,and IL-1β,and upregulated the expression of PI3K and p-Akt/Akt.Conclu-sion:Gaoyou-7 Pill ameliorates AKI through multi-component,multi-target,and multi-pathway mechanisms,primarily by modu-lating the PI3K/Akt pathway and suppressing inflammatory cytokine production,thereby preserving renal function.These findings provide a theoretical foundation for the rational clinical application and further development of Mongolian medicine.

杨雨霏;邬国栋;郭叶;薄彧坤;杨丹;安明

内蒙古科技大学包头医学院药学院,内蒙古 包头 014040内蒙古科技大学包头医学院药学院,内蒙古 包头 014040内蒙古科技大学包头医学院药学院,内蒙古 包头 014040内蒙古科技大学包头医学院药学院,内蒙古 包头 014040内蒙古科技大学包头医学院药学院,内蒙古 包头 014040内蒙古科技大学包头医学院药学院,内蒙古 包头 014040

医药卫生

高尤-7味丸急性肾损伤网络药理学分子对接实验验证

Gaoyou-7 PillAcute kidney injuryNetwork pharmacologyMolecular dockingExperimental verification

《海南医科大学学报》 2026 (9)

707-720,14

This study was supported by the National Natural Science Foundation of China(82460807)Natural Science Foundation of Inner Mongolia Autonomous Region(2023MS08046)Central Guidance for Local Science and Technology Projects(2022ZY0167)Standardization Project of Mongolian Medicine in Inner Mongolia Autonomous Region(2023MB031) 国家自然科学基金(82460807)内蒙古自治区自然科学基金项目(2023MS08046)中央引导地方科技项目(2022ZY0167)内蒙古自治区蒙医药标准化项目(2023MB031)

10.13210/j.cnki.jhmu.20250227.004

评论